I
Infinant Health
Dedicated to developing the next generation of products to establish, restore, and maintain a healthy human gut microbiome
About Infinant Health
Evolve BioSystems is a health-focused startup that operates in the infant nutrition market. The company specializes in developing products that enhance the gut microbiome of infants, thereby laying a strong foundation for their overall health. Their primary offering is a probiotic powder product called Evivo, which is designed to be mixed with breast milk. This product is based on the company's proprietary research and discovery of a bacterial strain known as B. infantis EVC001, which is believed to be crucial for infant health.
Read full description
Evolve BioSystems serves a broad range of clients, including parents, healthcare providers, and partners who are interested in promoting infant health. The company's business model revolves around the sale of its Evivo product, which is certified by Nutrasource's IPRO, a leading certification body in the health and nutrition industry. This certification adds credibility to the product and increases customer trust.
The company's revenue generation strategy is based on the direct sale of its Evivo product. Customers can learn more about the product and make purchases through the company's website or by contacting their customer service. The company also provides support to its customers, ensuring they understand how to use the product effectively.
In summary, Evolve BioSystems is a health and nutrition startup that leverages scientific research to develop products that enhance infant health by improving gut microbiome.
At a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Davis, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 81.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Synthetic Biology, Spinout, Biotech and Pharma, Woman Founder, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Infinant Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2026 | $39M | $275M | Undisclosed | ↗ |
| SERIES DOther financing | May 2021 | $10M | $275M | Horizons Ventures · Bow Capital · Acre Venture Partners · Spruce Capital Partners | — |
Growth signals
Latest recorded traffic for Infinant Health is 1.3K monthly website visits, up 18.2% over the last three months. Infinant Health's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Horizons Ventures
Tate & Lyle Ventures
Spruce Capital Partners
Bow Capital
Acre Venture Partners
Series B and later4 investors entered at this stage
Horizon Ventures
Bill & Melinda Gates Foundation
Cargill Ventures
Li Ka Shing Foundation
Other known investors1 additional known investor
Universiry of California, Davis
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Infinant Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Infinant Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.